Clinical trials
Phase 1 Multiple Myeloma trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 4 |
| Sanofi | 2 |
| BioInvent International AB | 1 |
| Celgene | 1 |
| Celyad Oncology SA | 1 |
| Genentech, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Jules Bordet Institute | 1 |
| Novartis Pharmaceuticals | 1 |
| Teva Branded Pharmaceutical Products R&D LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 15 |
| Recurrence | 2 |
| Amyloidosis | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Glioblastoma | 1 |
| Immunoglobulin Light-chain Amyloidosis | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.